Want to join the conversation?
Specialty biopharmaceutical company $MNK reported its 4Q15 gross profit of $482.1MM, up 32.7% over prior-year quarter, primarily due to the performance of Acthar and INOMAX products from Specialty Brands segment. Adjusted gross profit as a percentage of net sales was 72.4% compared to 66.5% in the same prior year period.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?